AXSOME THERAPEUTICS, INC. Increase (Decrease) in Other Noncurrent Assets
AXSOME THERAPEUTICS, INC. (AXSM) reported Increase (Decrease) in Other Noncurrent Assets of $184.55 thousand for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2022-08-09
- AXSOME THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2021-12-31 was $0.00.
- AXSOME THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2020-12-31 was $0.00.
- AXSOME THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2020-03-31 was $3.70K.
- AXSOME THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2019-12-31 was -$29.09K.
- AXSOME THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2021 was $5.54K, a 96.88% decline from fiscal 2020.
- AXSOME THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2020 was $177.50K, a 544.75% increase from fiscal 2019.
- AXSOME THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2019 was $27.53K.
- AXSOME THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2018 was -$75.61K, a 200.63% decline from fiscal 2017.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2022-06-30 | $184.55K 10-Q · filed 2022-08-09 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $5.54K 10-K · filed 2022-03-01 | ||
| 2021-09-30 | $5.54K 10-Q · filed 2021-11-08 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $177.50K 10-K · filed 2022-03-01 | ||
| 2020-09-30 | $177.50K 10-Q · filed 2021-11-08 | |||
| 2020-03-31 | $3.70K 10-Q · filed 2021-05-10 | -$25.39K derived: sum of 2 quarters · filed 2022-03-01 | -$25.39K derived: sum of 3 quarters · filed 2022-03-01 | $42.06K derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | -$29.09K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$29.09K derived: sum of 2 quarters · filed 2022-03-01 | $38.36K derived: sum of 3 quarters · filed 2022-03-01 | $27.53K 10-K · filed 2022-03-01 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $67.45K derived: sum of 2 quarters · filed 2020-11-05 | $56.62K 10-Q · filed 2020-11-05 | $51.61K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $67.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $56.62K 10-Q · filed 2020-08-10 | $51.61K derived: sum of 3 quarters · filed 2021-03-01 | $51.61K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | -$10.83K 10-Q · filed 2020-05-11 | -$15.84K derived: sum of 2 quarters · filed 2021-03-01 | -$15.84K derived: sum of 3 quarters · filed 2021-03-01 | -$13.37K derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | -$5.01K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$5.01K derived: sum of 2 quarters · filed 2021-03-01 | -$2.54K derived: sum of 3 quarters · filed 2021-03-01 | -$75.61K 10-K · filed 2021-03-01 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $2.47K derived: sum of 2 quarters · filed 2019-11-07 | -$70.60K 10-Q · filed 2019-11-07 | -$1.94K derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | $2.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$70.60K 10-Q · filed 2019-08-08 | -$1.94K derived: sum of 3 quarters · filed 2020-03-12 | -$1.94K derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | -$73.06K 10-Q · filed 2019-05-09 | -$4.40K derived: sum of 2 quarters · filed 2020-03-12 | -$4.40K derived: sum of 3 quarters · filed 2020-03-12 | -$4.40K derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | $68.66K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $68.66K derived: sum of 2 quarters · filed 2020-03-12 | $68.66K derived: sum of 3 quarters · filed 2020-03-12 | $75.13K 10-K · filed 2020-03-12 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $0.00 derived: sum of 2 quarters · filed 2018-11-09 | $6.47K 10-Q · filed 2018-11-09 | $60.17K derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $6.47K 10-Q · filed 2018-08-08 | $60.17K derived: sum of 3 quarters · filed 2019-03-15 | $61.79K derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-03-31 | $6.47K 10-Q · filed 2018-05-08 | $60.17K derived: sum of 2 quarters · filed 2019-03-15 | $61.79K derived: sum of 3 quarters · filed 2019-03-15 | $61.79K derived: sum of 4 quarters · filed 2019-03-15 |
| 2016-12-31 | $53.70K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $55.32K derived: sum of 2 quarters · filed 2019-03-15 | $55.32K derived: sum of 3 quarters · filed 2019-03-15 | $86.20K 10-K · filed 2019-03-15 |
| 2016-09-30 | $1.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $1.63K derived: sum of 2 quarters · filed 2017-11-08 | $32.50K 10-Q · filed 2017-11-08 | $36.13K derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $30.88K 10-Q · filed 2017-08-09 | $34.50K derived: sum of 3 quarters · filed 2018-03-07 | |
| 2016-03-31 | $30.88K 10-Q · filed 2017-05-09 | $34.50K derived: sum of 2 quarters · filed 2018-03-07 | ||
| 2015-12-31 | $3.63K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $26.63K 10-K · filed 2018-03-07 | ||
| 2015-09-30 | $23.00K 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |